SEC Form 4 · accession 0001179110-15-012463
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Braunstein
Director
Period of report
Aug 19, 2015
Accepted (ET)
Aug 21, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $57.54 | Aug 19, 2015 | A | 20,000 | A | — | Aug 19, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Vests in equal monthly installments rounded down to the nearest whole share over the 36 months following June 15, 2015